BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 266986)

  • 1. [Megakaryocytic myelosis: clinical and morphological features (author's transl)].
    Prechtel K; Beil E; Kronseder A
    Dtsch Med Wochenschr; 1977 Jun; 102(23):853-7. PubMed ID: 266986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative clinical and histological investigations in chronic myeloid leukaemias ].
    Seewann HL; Jüttner F; Vykoupil KF
    Wien Klin Wochenschr; 1982 May; 94(10):270-2. PubMed ID: 6957071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathologc findings in megakaryocytic myelosis (author's transl)].
    Schäfer R; Schueider HM; Hill K
    Zentralbl Allg Pathol; 1977; 121(3):263-72. PubMed ID: 899319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Megakaryocytic myelosis--cause of "idiopathic" thrombocythemia].
    Burkhardt R; Kronseder A
    Fortschr Med; 1977 May; 95(19):1261-6. PubMed ID: 863367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocythaemia - is there a primary form? ((author's transl)].
    Hartwich G; Schirmbeck H; Mörl M
    Med Klin; 1975 Dec; 70(49):2005-8. PubMed ID: 1060913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
    Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
    Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Megakaryocytic pseudomyelosis with severe thrombocytosis].
    Krug K; Rohrberg R; Wessel H
    Z Gesamte Inn Med; 1981 Oct; 36(19):734-7. PubMed ID: 6171109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous megakaryocytic colony formation does not discriminate between essential thrombocythemia and polycythemia vera.
    Escoffre-Barbe M; Amiot L; Beaucournu P; Jego P; Grulois I; Grosbois B; Bernard M; Fest T; Lamy T; Fardel O
    Am J Hematol; 2006 Jul; 81(7):554-6. PubMed ID: 16755572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J; Funke S; Holgado S; Choritz H; Georgii A
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megakaryoblastic transformation of a myeloproliferative disorder.
    Prematilleke MN; Cheng PN; Feng CS
    Ceylon Med J; 1989 Dec; 34(4):179-84. PubMed ID: 2627727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of bone marrow biopsy in chronic myeloid leukaemia.
    Seewann HL; Lehnert M; Jüttner F
    Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary and secondary thrombocythemia: apropos of 39 cases].
    Bernadou A; Loo H; Prost RJ; Doumenc J; Zittoun R; Bilski-Pasquier G
    Sem Hop; 1968 Jun; 44(31):2092-100. PubMed ID: 4300454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
    Cervantes F; Alcorta I; Bosch F; Vives-Corrons JL; Rozman C
    Sangre (Barc); 1992 Feb; 37(1):1-3. PubMed ID: 1585231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.